SGLT2-inhibitors are effective and safe in the elderly: The SOLD study

SGLT2-inhibitors are effective and safe in the elderly: The SOLD study

Background and aims: Sodium-glucose co-transporter-2 inhibitors (SGLT2i) may have important benefits for the elderly with type 2 diabetes (T2D), however some safety concerns still limit their use in patients over 70 years of age. The SOLD study (SGLT2i in Older Diabetic patients) is a multicenter st...

Full description

Bibliographic Details
Main Authors: Maria Elena Lunati, Vincenzo Cimino, Alessandra Gandolfi, Matteo Trevisan, Laura Montefusco, Ida Pastore, Camilla Pace, Nazarena Betella, Giuseppe Favacchio, Monica Bulgheroni, Loredana Bucciarelli, Giulia Massari, Cristina Mascardi, Angela Girelli, Paola Silvia Morpurgo, Franco Folli, Livio Luzi, Marco Mirani, Basilio Pintaudi, Federico Bertuzzi, Cesare Berra, Paolo Fiorina
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Pharmacological Research
Subjects:
SGLT2-I
T2D
Safety
Online Access:http://www.sciencedirect.com/science/article/pii/S1043661822003413

Internet

http://www.sciencedirect.com/science/article/pii/S1043661822003413

Similar Items